ADVERSE REACTIONS

griseofulvin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. guanfacinetadalafil increases effects of guanfacine by pharmacodynamic synergism. tadalafil increases effects of guanfacine by pharmacodynamic synergism.

hydralazinetadalafil increases effects of hydralazine by pharmacodynamic synergism.

PDE-5 Inhibitors Come With Drawbacks

tadalafil increases effects of enalapril by pharmacodynamic synergism. Encorafenib both inhibits and induces CYP3A4 at clinically relevant plasma concentrations. Coadministration of encorafenib with sensitive CYP3A4 substrates may result in increased toxicity or decreased efficacy of these agents. eplerenonetadalafil increases effects of eplerenone by pharmacodynamic synergism. tadalafil increases effects of eplerenone by pharmacodynamic synergism.

Cialis once-daily regimen for ED and BPH

eprosartantadalafil increases effects of eprosartan by pharmacodynamic synergism. tadalafil increases effects of eprosartan by pharmacodynamic synergism. eslicarbazepine acetate will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. esmololtadalafil increases effects of esmolol by pharmacodynamic synergism. tadalafil increases effects of esmolol by pharmacodynamic synergism. tadalafil increases effects of hydralazine by pharmacodynamic synergism. hydrochlorothiazidetadalafil increases effects of hydrochlorothiazide by pharmacodynamic synergism. tadalafil increases brand cialis canadian pharmacy effects of hydrochlorothiazide by pharmacodynamic synergism. imatinibimatinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. imatinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. indapamidetadalafil increases effects of indapamide by pharmacodynamic synergism. tadalafil increases effects of indapamide by pharmacodynamic synergism. irbesartantadalafil increases effects of irbesartan by pharmacodynamic synergism. tadalafil increases effects of irbesartan by pharmacodynamic synergism. isoniazidisoniazid will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. isoniazid will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. isradipinetadalafil increases effects of isradipine by pharmacodynamic synergism. tadalafil increases effects of isradipine by pharmacodynamic synergism. istradefyllineistradefylline will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Istradefylline 40 mg/day increased peak levels and AUC of CYP3A4 substrates in clinical trials. This effect was not observed with istradefylline 20 mg/day. Consider dose reduction of sensitive CYP3A4 substrates.

• Cialis 10mg tablets should be stored in a cool, dry environment.
• Protect the medication from direct sunlight and moisture.
• Proper storage ensures medication stability and safety.
• Keep Cialis out of sight and reach of children and pets.
• Do not use expired Cialis tablets; dispose of them safely.
• Store away from heat sources to prevent degradation.
• Use original packaging to keep track of medication.
• If you experience any storage issues, consult your pharmacist.
• Keep a record of medication expiry dates for safety.
• Avoid storing Cialis in the bathroom due to humidity.
• Use a designated medication container for safe storage.

istradefylline will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. labetaloltadalafil increases effects of labetalol by pharmacodynamic synergism. tadalafil increases effects of labetalol by pharmacodynamic synergism. lapatiniblapatinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lapatinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. letermovirletermovir increases levels of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

• Cialis tadalafil 10mg tablets are available by prescription only.
• Always take Cialis exactly as prescribed by your healthcare provider.
• It is important to disclose all health conditions before starting Cialis.
• Some men may experience nasal congestion or back pain as side effects.
• Discuss any concerns or side effects with your doctor promptly.
• Cialis is not intended for recreational use or non-medical enhancement.
• Use caution when combining Cialis with other vasodilators.
• Regular cardiovascular assessment is recommended for long-term users.
• Avoid using Cialis if you have a history of allergic reactions.
• Always check for interactions if taking other prescription or OTC drugs.
• Consult your healthcare provider about the safety of Cialis for your condition.

letermovir increases levels of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lisinopriltadalafil increases effects of lisinopril by pharmacodynamic synergism. tadalafil increases effects of lisinopril by pharmacodynamic synergism. losartantadalafil increases effects of losartan by pharmacodynamic synergism. tadalafil increases effects of losartan by pharmacodynamic synergism. lumefantrinelumefantrine will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lumefantrine will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. marijuanamarijuana will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. marijuana will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

mavorixaformavorixafor will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor for adverse effects of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor). mavorixafor will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Society and culture

furosemidetadalafil increases effects of furosemide by pharmacodynamic synergism. tadalafil increases effects of furosemide by pharmacodynamic synergism. grapefruitgrapefruit will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. grapefruit will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvingriseofulvin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metolazonetadalafil increases effects of metolazone by pharmacodynamic synergism. tadalafil increases effects of metolazone by pharmacodynamic synergism. metoprololtadalafil increases effects of metoprolol by pharmacodynamic synergism.

What should I know about storage and disposal of this medication?

fluconazolefluconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fluconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fluvoxaminefluvoxamine will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fluvoxamine will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosaprepitantfosaprepitant will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Muscular Dystrophy (Orphan)

fosaprepitant will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosinopriltadalafil increases effects of fosinopril by pharmacodynamic synergism. tadalafil increases effects of fosinopril by pharmacodynamic synergism. fosphenytoinfosphenytoin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosphenytoin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tadalafil increases effects of metoprolol by pharmacodynamic synergism. metronidazolemetronidazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. mifepristonemifepristone will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. mifepristone will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. minoxidiltadalafil increases effects of minoxidil by pharmacodynamic synergism.

More about tadalafil

ethacrynic acidtadalafil increases effects of ethacrynic acid by pharmacodynamic synergism. tadalafil increases effects of ethacrynic acid by pharmacodynamic synergism. Combination may increase risk of orthostatic hypotension, tachycardia, dizziness and headache. etravirineetravirine will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. etravirine will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Patient resources

fedratinibfedratinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Adjust dose of drugs that are CYP3A4 substrates as necessary. fedratinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. felodipinetadalafil increases effects of felodipine by pharmacodynamic synergism. tadalafil increases effects of felodipine by pharmacodynamic synergism. tadalafil increases effects of minoxidil by pharmacodynamic synergism. mitotanemitotane decreases levels of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Mitotane is a strong inducer of cytochrome P-4503A4; monitor when coadministered with CYP3A4 substrates for possible dosage adjustments. mitotane decreases levels of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

8.6 Hepatic Impairment

Coadministration with duvelisib increases AUC of a sensitive CYP3A4 substrate which may increase the risk of toxicities of these drugs. Consider reducing the dose of the sensitive CYP3A4 substrate and monitor for signs of toxicities of the coadministered sensitive CYP3A substrate. duvelisib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenzefavirenz will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenz will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Long-term use

elagolixelagolix decreases levels of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Consider increasing CYP3A substrate dose if needed. elagolix decreases levels of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Adjust tadalafil dose for PAH; if on Stribild, start tadalafil 20 mg/day; avoid tadalafil when starting Stribild; for ED, a single dose of tadalafil not exceeding 10 mg in 72 hr. enalapriltadalafil increases effects of enalapril by pharmacodynamic synergism. nadololtadalafil increases effects of nadolol by pharmacodynamic synergism.

tadalafil increases effects of nadolol by pharmacodynamic synergism. nafcillinnafcillin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

• Cialis tadalafil 10mg tablets are sometimes used off-label for other conditions.
• Always consult your doctor before using Cialis for any unapproved purpose.
• The medication's use should always be part of a comprehensive health plan.
• Adherence to medical advice enhances treatment success.
• Cialis is a prescription medication, and self-medicating is risky.
• Regular communication with your healthcare provider helps monitor effects.
• Any significant health changes should be reported during Cialis therapy.
• Be aware of the potential for drug interactions impacting efficacy.
• Use medical resources to understand proper usage and precautions.
• Keep informed about new research regarding Cialis and related drugs.
• Responsible use of Cialis improves safety and satisfaction.

nafcillin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.